LIEN logo

Chicago Atlantic BDC, Inc. (LIEN)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Chicago Atlantic BDC, Inc. (LIEN) trades at $9.67 with AI Score 67/100 (Buy). Chicago Atlantic BDC, Inc. is a specialty finance company focused on the cannabis industry. Market cap: 221M, Sector: Financial services.

Last analyzed: Feb 8, 2026
Chicago Atlantic BDC, Inc. is a specialty finance company focused on the cannabis industry. They provide direct loans and equity investments to privately held cannabis companies.
67/100 AI Score Target $11.00 (+13.8%) MCap 221M Vol 135K

Chicago Atlantic BDC, Inc. (LIEN) Financial Services Profile

CEOPeter S. Sack
HeadquartersNew York City, NY, US
IPO Year2022

Chicago Atlantic BDC (LIEN) offers investors a unique opportunity to capitalize on the burgeoning cannabis industry through direct lending and equity investments, boasting a high dividend yield of 13.45% and a strong profit margin of 82.7%, positioning it as a compelling income-generating asset.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Chicago Atlantic BDC presents a notable research candidate due to its unique focus on the high-growth cannabis industry and its attractive dividend yield of 13.45%. The company's strong profit margin of 82.7% and gross margin of 98.8% demonstrate efficient operations and a solid business model. As the cannabis industry continues to mature and regulatory hurdles are reduced, Chicago Atlantic is poised to benefit from increased demand for capital. The company's expertise in navigating the complexities of cannabis financing, coupled with its established network of industry partners, provides a competitive edge. With a market capitalization of $0.23 billion and a low beta of 0.22, LIEN offers a blend of growth potential and relative stability. Investors may want to evaluate LIEN as a high-yield income investment with potential for capital appreciation as the cannabis market expands.

Based on FMP financials and quantitative analysis

Key Highlights

  • Dividend Yield: 13.45%, offering a substantial income stream for investors.
  • Profit Margin: 82.7%, indicating efficient operations and strong profitability.
  • Gross Margin: 98.8%, reflecting a high level of efficiency in generating revenue.
  • Market Cap: $0.23B, representing a relatively small but potentially high-growth company.
  • P/E Ratio: 6.99, suggesting the company may be undervalued compared to its earnings.

Competitors & Peers

Strengths

  • High dividend yield of 13.45% attracts income-seeking investors.
  • Strong profit margin of 82.7% demonstrates efficient operations.
  • Specialized expertise in the cannabis industry provides a competitive advantage.
  • Established network of industry partners facilitates deal sourcing.

Weaknesses

  • Concentrated exposure to the cannabis industry, which is subject to regulatory uncertainty.
  • Relatively small market capitalization may limit liquidity.
  • Dependence on the performance of cannabis companies, which can be volatile.
  • Limited diversification compared to broader investment firms.

Catalysts

  • Upcoming: Further legalization of cannabis in additional states and countries, expanding the market opportunity.
  • Ongoing: Continued growth in consumer demand for cannabis products, driving revenue growth for cannabis companies.
  • Ongoing: Maturation of the cannabis industry, leading to increased stability and profitability.
  • Ongoing: Potential for federal cannabis reform in the United States, reducing regulatory burdens.

Risks

  • Potential: Regulatory changes could negatively impact the cannabis industry.
  • Potential: Increased competition could reduce margins and market share.
  • Potential: Economic downturn could reduce demand for cannabis products.
  • Ongoing: Dependence on the performance of cannabis companies, which can be volatile.
  • Ongoing: Difficulty in predicting the long-term growth and profitability of the cannabis industry.

Growth Opportunities

  • Expansion of Lending Activities: As more states and countries legalize cannabis, the demand for financing will increase significantly. Chicago Atlantic can capitalize on this trend by expanding its lending activities to new markets, focusing on states with favorable regulatory environments and high growth potential. This expansion could involve establishing new partnerships with cannabis operators and increasing the size of its loan portfolio. The market size for cannabis financing is estimated to reach billions of dollars in the coming years, providing ample opportunity for growth.
  • Strategic Equity Investments: In addition to lending, Chicago Atlantic can pursue strategic equity investments in promising cannabis companies. This approach allows the company to participate directly in the upside potential of these businesses, generating higher returns than traditional lending. By carefully selecting companies with strong management teams, innovative products, and defensible market positions, Chicago Atlantic can create a portfolio of high-growth equity investments. The timeline for realizing returns on these investments will vary depending on the specific company and market conditions.
  • Development of New Financial Products: Chicago Atlantic can further diversify its revenue streams by developing new financial products tailored to the specific needs of the cannabis industry. This could include specialized loans for cultivation facilities, processing plants, and retail dispensaries, as well as innovative financing solutions for cannabis-related technology companies. By offering a comprehensive suite of financial products, Chicago Atlantic can become a one-stop shop for cannabis businesses seeking capital.
  • Mergers and Acquisitions: As the cannabis industry consolidates, Chicago Atlantic can play a role in facilitating mergers and acquisitions. The company can provide financing to support these transactions, earning fees and interest income. By leveraging its industry expertise and network, Chicago Atlantic can identify attractive acquisition targets and help its clients execute successful deals. This strategy can generate significant value for Chicago Atlantic and its investors.
  • Expansion into Hemp and CBD Markets: While Chicago Atlantic's primary focus is on the cannabis industry, it can also expand its activities into the related hemp and CBD markets. These markets are experiencing rapid growth, driven by increasing consumer demand for hemp-based products and the growing acceptance of CBD as a wellness supplement. By providing financing to hemp and CBD companies, Chicago Atlantic can further diversify its revenue streams and capitalize on the broader trends in the cannabis and hemp industries.

Opportunities

  • Expansion into new cannabis markets as legalization efforts progress.
  • Development of new financial products and services for the cannabis industry.
  • Strategic acquisitions of complementary businesses.
  • Increased institutional investor interest in the cannabis sector.

Threats

  • Changes in cannabis regulations could negatively impact the industry.
  • Increased competition from other lenders and investors.
  • Economic downturn could reduce demand for cannabis products.
  • Potential for defaults on loans to cannabis companies.

Competitive Advantages

  • Specialized industry expertise in cannabis financing.
  • Established network of industry partners.
  • Strong relationships with private equity firms.
  • Proprietary deal sourcing capabilities.

About LIEN

Chicago Atlantic BDC, Inc., formerly known as Silver Spike Investment Corp., was established in 2021 with a clear mission: to provide tailored financial solutions to businesses operating within the rapidly expanding cannabis ecosystem. Recognizing the challenges these companies face in accessing traditional financing, Chicago Atlantic focuses on deploying capital through direct loans and strategic equity investments. The company actively partners with private equity firms, seasoned entrepreneurs, business owners, and experienced management teams, offering a range of credit and equity financing alternatives. These solutions support critical activities such as buyouts, recapitalizations, strategic growth initiatives, refinancings, and synergistic acquisitions. Chicago Atlantic's investment scope encompasses a diverse array of cannabis-related ventures, including cannabis-enabling technology companies that provide essential infrastructure and tools, health and wellness companies developing innovative cannabis-based products, and hemp and CBD distribution companies facilitating market access. Headquartered in New York City, Chicago Atlantic is strategically positioned to capitalize on the evolving regulatory landscape and emerging opportunities within the cannabis sector, aiming to generate attractive risk-adjusted returns for its investors while fostering sustainable growth within the industry.

What They Do

  • Provides direct loans to privately held cannabis companies.
  • Makes equity investments in cannabis businesses.
  • Partners with private equity firms and entrepreneurs in the cannabis sector.
  • Offers financing for buyouts, recapitalizations, and acquisitions.
  • Supports growth initiatives and refinancings for cannabis companies.
  • Invests in cannabis-enabling technology companies.
  • Finances cannabis-related health and wellness companies.
  • Provides capital to hemp and CBD distribution companies.

Business Model

  • Generates revenue through interest income from direct loans.
  • Earns capital gains from equity investments.
  • Collects fees for providing financial advisory services.
  • Partners with other financial institutions to syndicate larger loans.

Industry Context

Chicago Atlantic BDC operates within the rapidly evolving cannabis industry, which is experiencing significant growth as legalization efforts expand across the United States and globally. The industry faces unique challenges in accessing traditional financial services, creating a niche market for specialized lenders like Chicago Atlantic. The competitive landscape includes other business development companies and private credit funds focused on the cannabis sector. Chicago Atlantic's deep industry expertise and established network position it favorably to capitalize on the increasing demand for capital within the cannabis market. As the industry matures, companies like Chicago Atlantic will play a crucial role in providing the necessary funding for growth and expansion.

Key Customers

  • Cannabis cultivators and growers.
  • Cannabis processors and manufacturers.
  • Cannabis retailers and dispensaries.
  • Cannabis technology companies.
  • Hemp and CBD product distributors.
AI Confidence: 72% Updated: Feb 8, 2026

Financials

Chart & Info

Chicago Atlantic BDC, Inc. (LIEN) stock price: $9.67 (-0.04, -0.41%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LIEN.

Price Targets

Consensus target: $11.00

MoonshotScore

67/100

What does this score mean?

The MoonshotScore rates LIEN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Common Questions About LIEN

What does Chicago Atlantic BDC, Inc. do?

Chicago Atlantic BDC, Inc. is a specialty finance company that focuses on providing capital to businesses operating in the cannabis industry. They offer direct loans and make equity investments in privately held cannabis companies, partnering with private equity firms, entrepreneurs, and management teams. Their financing solutions support various activities, including buyouts, recapitalizations, growth initiatives, refinancings, and acquisitions. The company targets cannabis-enabling technology companies, cannabis-related health and wellness companies, and hemp and CBD distribution companies, providing critical financial support to a rapidly growing sector.

Is LIEN stock worth researching?

LIEN stock presents a potentially attractive investment opportunity, primarily driven by its high dividend yield of 13.45% and strong profit margin of 82.7%. The company's focus on the cannabis industry offers exposure to a high-growth market, but also carries inherent risks related to regulatory uncertainty and competition. Investors should carefully consider their risk tolerance and conduct thorough due diligence before investing. While the company's financials appear strong, the cannabis industry is still evolving, and future performance is not guaranteed. A diversified portfolio and a long-term investment horizon are recommended.

What are the main risks for LIEN?

The main risks for LIEN are primarily related to the cannabis industry's regulatory landscape and competitive environment. Changes in cannabis regulations, such as increased taxes or stricter licensing requirements, could negatively impact the profitability of cannabis companies and, consequently, LIEN's loan portfolio. Increased competition from other lenders and investors could also reduce LIEN's margins and market share. An economic downturn could reduce consumer demand for cannabis products, leading to potential defaults on loans. Investors should carefully monitor these risks and assess their potential impact on LIEN's financial performance.

What are the key factors to evaluate for LIEN?

Chicago Atlantic BDC, Inc. (LIEN) currently holds an AI score of 67/100, indicating moderate score. The stock trades at a P/E of 6.6x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $11.00 (+14% from $9.67). Key strength: High dividend yield of 13.45% attracts income-seeking investors.. Primary risk to monitor: Potential: Regulatory changes could negatively impact the cannabis industry.. This is not financial advice.

How frequently does LIEN data refresh on this page?

LIEN prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven LIEN's recent stock price performance?

Recent price movement in Chicago Atlantic BDC, Inc. (LIEN) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $11.00 implies 14% upside from here. Notable catalyst: High dividend yield of 13.45% attracts income-seeking investors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider LIEN overvalued or undervalued right now?

Determining whether Chicago Atlantic BDC, Inc. (LIEN) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 6.6. Analysts target $11.00 (+14% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying LIEN?

Before investing in Chicago Atlantic BDC, Inc. (LIEN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • The cannabis industry is subject to rapid regulatory changes, which could impact the company's future performance.
  • Financial data is based on publicly available information and may be subject to change.
  • Investment decisions should be based on individual risk tolerance and financial circumstances.
Data Sources

Popular Stocks